All Stories

  1. Chronic inflammatory demyelinating polyneuropathy and malignancy: A systematic review
  2. Serial electrophysiology in Guillain-Barré syndrome: A retrospective cohort and case-by-case multicentre analysis
  3. Prevalence, correlates and impact of pain and cramps in anti-MAG neuropathy: a multicentre European study
  4. Poems and “MGUS-related neuropathy”: Electrophysiologically different but in many ways
  5. Neuropsychiatric manifestations in inflammatory neuropathies: A systematic review
  6. Steroids for chronic inflammatory demyelinating polyradiculoneuropathy: evidence base and clinical practice
  7. Effects of low frequency filtering on distal compound muscle action potential duration for diagnosis of CIDP: A Japanese–European multicenter prospective study
  8. Hyponatraemia in Guillain-Barré syndrome revisited
  9. Disease status in chronic inflammatory demyelinating polyneuropathy: inter-centre comparative analysis and correlates
  10. Which criteria for research in chronic inflammatory demyelinating polyradiculoneuropathy? an analysis of current practice
  11. Long-term Immunoglobulin therapy for chronic inflammatory demyelinating polyradiculoneuropathy
  12. The value of ultrasonography versus clinical examination in differentiating acute inflammatory demyelinating polyneuropathy from acute-onset chronic inflammatory demyelinating polyneuropathy: The importance of timing
  13. Health-related quality of life in chronic inflammatory neuropathies: A systematic review
  14. Two, three, or four-limb testing? Or the difficulties of optimizing electrodiagnosis for suspected CIDP
  15. Diagnostic value of MR imaging in the Lewis–Sumner syndrome: A case series
  16. Electrophysiological diagnosis of Guillain–Barré syndrome subtype: could a single study suffice?
  17. Optic and auditory pathway dysfunction in demyelinating neuropathies
  18. Compound muscle action potential amplitude and distal potential duration in axonal neuropathy
  19. Subcutaneous immunoglobulin therapy for inflammatory neuropathy: current evidence base and future prospects
  20. Immunomodulation in Inflammatory Neuropathies: Rationale and Safety
  21. High resolution optical coherence tomography of the retina demonstrates selective thinning in individual retinal layers in Parkinson's disease
  22. Levodopa, vitamins, ageing and the neuropathy of Parkinson’s disease
  23. Knowledge of TIA among general practitioners and emergency department physicians. A questionnaire survey in a French semi-rural area
  24. Chronic inflammatory demyelinating polyradiculoneuropathy
  25. Facial Onset Sensory Motor Neuronopathy
  26. Immunoglobulin G level variations in treated chronic inflammatory demyelinating polyneuropathy: clues for future treatment regimens?
  27. Insulin Neuritis and Diabetic Cachectic Neuropathy: A Review
  28. Restless legs syndrome in sensory axonal neuropathy: A case-control study
  29. Prospective study of POLG mutations presenting in children with intractable epilepsy: Prevalence and clinical features
  30. Jamar hand-held grip dynamometry in chronic inflammatory demyelinating polyneuropathy
  31. A Rare Cause of Late-Onset Cerebellar Ataxia: Erdheim–Chester Disease
  32. Practical electrodiagnostic value of F-wave studies in chronic inflammatory demyelinating polyneuropathy
  33. A RARE FORM OF BRACHIAL NEURITIS
  34. No association between neuropathy and restless legs in Parkinson's disease
  35. Diagnosis, epidemiology and treatment of inflammatory neuropathies
  36. Treatment of Guillain-Barre Syndrome: A Review
  37. Outcome and its predictors in Guillain–Barré syndrome
  38. Common and Less Common Peripheral Nerve Disorders Associated with Diabetes
  39. Chronic inflammatory demyelinating polyneuropathy associated with alopecia totalis and Sjögren syndrome
  40. Chronic Inflammatory Pure Sensory Polyradiculoneuropathy
  41. A European multicentre reappraisal of distal compound muscle action potential duration in chronic inflammatory demyelinating polyneuropathy
  42. Neuropathy in Parkinson disease: Prevalence and determinants
  43. Thromboembolic complications of intravenous immunoglobulin therapy in patients with neuropathy: A two-year study
  44. Optic neuropathy associated with CANOMAD: Description of 2 cases
  45. Median nerve ultrasonography in distinguishing neuropathy sub-types: a pilot study
  46. Demyelinating neuropathy with anti-CRMP5 antibodies predating diagnosis of breast carcinoma: Favorable outcome after cancer therapy
  47. Elderly patients with epileptic seizures: In-patient observational study of two French community hospitals
  48. Motor and sensory conduction failure in overlap of Guillain–Barré and Miller Fisher syndrome: Two simultaneous cases
  49. Neuropathy and paraproteins: review of a complex association
  50. Value of distal compound muscle action potential duration prolongation in acute inflammatory demyelinating polyneuropathy: A European perspective
  51. Dyslipidaemia in chronic acquired distal axonal polyneuropathy
  52. Distribution, clinical correlates and significance of axonal loss and demyelination in chronic inflammatory demyelinating polyneuropathy
  53. Multi-focal motor neuropathy: one treatment works but many uncertainties remain
  54. Electrophysiologic entrapment syndromes in chronic inflammatory demyelinating polyneuropathy
  55. Steroid-Induced Inflammatory Neuropathy in a Patient on Tumor Necrosis Factor-α Antagonist Therapy
  56. POI12 Electrophysiological sensory demyelination in typical chronic inflammatory demyelinating polyneuropathy
  57. Characteristics and correlates of sensory function in chronic inflammatory demyelinating polyneuropathy
  58. Neuropathy and impaired glucose tolerance: an updated review of the evidence
  59. Charcot-Marie-Tooth Disease due to Novel Myelin Protein Zero Mutation Presenting as Late-Onset Remitting Sensory Neuropathy
  60. Restless legs syndrome in chronic inflammatory demyelinating polyneuropathy
  61. Identification of novel and recurrent CACNA1A gene mutations in fifteen patients with episodic ataxia type 2
  62. Overview of the pathogenesis and treatment of chronic inflammatory demyelinating polyneuropathy with intravenous immunoglobulins
  63. Electrophysiological sensory demyelination in typical chronic inflammatory demyelinating polyneuropathy
  64. Current Proposed Mechanisms of Action of Intravenous Immunoglobulins in Inflammatory Neuropathies
  65. Immune therapy for chronic inflammatory demyelinating polyneuropathy: from clinical trials to real-life
  66. Electrophysiological markers of large fibre sensory neuropathy: a study of sensory and motor conduction parameters
  67. Neuroleptic malignant syndrome and acute motor axonal neuropathy after Campylobacter jejuni infection
  68. Vertical optokinetic nystagmus in Parkinson's disease
  69. Validity of diagnostic criteria for chronic inflammatory demyelinating polyneuropathy: a multicentre European study
  70. Sensori-motor Guillain-Barré syndrome with anti-GD1b antibodies following influenza A infection
  71. Epidemiologic variability of chronic inflammatory demyelinating polyneuropathy with different diagnostic criteria: Study of a UK population
  72. Lewis-sumner syndrome of pure upper-limb onset: Diagnostic, prognostic, and therapeutic features
  73. Steroid-Responsive Paraneoplastic Demyelinating Neuropathy and Myelopathy Associated With Breast Carcinoma
  74. New pedigrees and novel mutation expand the phenotype of REEP1-associated hereditary spastic paraplegia (HSP)
  75. Post-Traumatic Short-Lasting Unilateral Headache With Cranial Autonomic Symptoms (SUNA)
  76. Chronic inflammatory demyelinating polyneuropathy–like disorder associated with amyotrophic lateral sclerosis
  77. Multifocal motor neuropathy: review of a treatable immune mediated disorder
  78. Electrophysiological predictors of steroidresponsiveness in chronic inflammatory demyelinating polyneuropathy
  79. Hypothermia in VGKC antibody-associated limbic encephalitis
  80. Charcot-Marie-Tooth disease type 1A associated with acute porphyric neuropathy
  81. The value of sensory electrophysiology in chronic inflammatory demyelinating polyneuropathy
  82. Chronic inflammatory demyelinating polyneuropathy after Mycoplasma pneumoniae infection
  83. Immunoglobulin-responsive dysautonomia in Sjögren's syndrome
  84. Short-Lasting Unilateral Neuralgiform Headache with Cranial Autonomic Symptoms (SUNA) Following Vertebral Artery Dissection
  85. Sensory Guillain-Barré syndrome after Campylobacter jejuni infection
  86. Dose of intravenous immunoglobulins in chronic inflammatory demyelinating polyneuropathy
  87. Proximal nerve conduction studies in chronic inflammatory demyelinating polyneuropathy
  88. Clinical heterogeneity in mild chronic inflammatory demyelinating polyneuropathy
  89. Acute motor conduction block neuropathy followed by axonal degeneration and poor recovery
  90. Neuropathies in the older patient
  91. Rapidly Progressive Bilateral Ophthalmoplegia and Enlarging Sellar Mass Caused by Amelanotic Melanoma
  92. Acute motor conduction block neuropathy followed by axonal degeneration and poor recovery
  93. Anti-GM1 antibody-negative acute motor axonal neuropathy after Mycoplasma pneumoniae infection
  94. Charcot-Marie-Tooth disease due to the Thr124Met mutation in the myelin protein zero gene associated with multiple sclerosis
  95. Hemicrania Continua Responsive to Verapamil
  96. Optimizing the use of electrophysiology in the diagnosis of chronic inflammatory demyelinating polyneuropathy: a study of 20 cases
  97. Hemiplegic ALS: Mills syndrome
  98. Brachial diplegia as a result of cervical cord injury
  99. Intracranial Hypertension Induced by Rofecoxib
  100. Intracranial Hypertension Associated With Transverse Myelitis
  101. Paraneoplastic brainstem encephalitis with tetraparesis in a patient with anti-Ri antibodies
  102. Disorder resembling Guillain-Barré syndrome on initiation of statin therapy
  103. Chronic inflammatory demyelinating polyneuropathy after Campylobacter jejuni infection mimicking vasculitic mononeuritis multiplex in a diabetic
  104. Neuropathy associated with lansoprazole treatment
  105. Successful treatment of indomethacin-intolerant chronic paroxysmal hemicrania: report of two cases
  106. A diabetic patient with recurrent tetraparesis
  107. Bilateral meralgia paraesthetica following repeated laparotomies
  108. Oro-Mandibular Dystonia in a Case of Multiple Sclerosis with Capsular Plaque
  109. Hypokalemic periodic paralysis associated with malignant hyperthermia
  110. Hypokalemic periodic paralysis associated with malignant hyperthermia
  111. Chronic inflammatory demyelinating polyneuropathy caused by HIV infection in a patient with asymptomatic CMT 1A
  112. Peripheral myelin modification in CMT1B correlates with MPZ gene mutations
  113. Parkinsonism as a result of a giant aneurysm
  114. Parkinsonism as a result of a giant aneurysm
  115. The endoneurial inflammatory reaction in 31 patients with onion-bulb formations
  116. Laparoscopic Ventrofixation